- €255.96m
- €247.48m
- €221.59m
- 85
- 67
- 49
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 71 | 106 | 170 | 264 | 222 |
Cost of Revenue | |||||
Gross Profit | 19.6 | 33.6 | 53 | 74.3 | 68.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 60.9 | 93.9 | 144 | 225 | 193 |
Operating Profit | 10.1 | 12.6 | 26 | 38.9 | 28.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.66 | 11.5 | 25.7 | 36.6 | 26.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.27 | 9.22 | 21.1 | 27.6 | 19.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 6.27 | 9.22 | 21.1 | 27.6 | 19.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6.27 | 9.22 | 21.1 | 27.6 | 19.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.247 | 0.404 | 0.719 | 0.942 | 0.645 |
Dividends per Share |